Main Menu

Publications Highlights View all by category

Types of Publications

Journal Articles

Galuppini, F. Censi, S. Merante Boschin, I. Fassan, M. Sbaraglia, M. Valeri, N. Hahne, J.C. Bertazza, L. Munari, G. Galasso, M. Cascione, L. Barollo, S. Rugge, M. Vianello, F. Dei Tos, A.P. Mian, C. Pennelli, G. (2022). Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling. , Vol.13, p. 834075.  show abstract

Lampis, A. Hahne, J.C. Gasparini, P. Cascione, L. Hedayat, S. Vlachogiannis, G. Murgia, C. Fontana, E. Edwards, J. Horgan, P.G. Terracciano, L. Sansom, O.J. Martins, C.D. Kramer-Marek, G. Croce, C.M. Braconi, C. Fassan, M. Valeri, N. (2021). MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer. Cell death and differentiation, .  show abstract

Tajan, M. Hennequart, M. Cheung, E.C. Zani, F. Hock, A.K. Legrave, N. Maddocks, O.D. Ridgway, R.A. Athineos, D. Suárez-Bonnet, A. Ludwig, R.L. Novellasdemunt, L. Angelis, N. Li, V.S. Vlachogiannis, G. Valeri, N. Mainolfi, N. Suri, V. Friedman, A. Manfredi, M. Blyth, K. Sansom, O.J. Vousden, K.H. (2021). Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy. Nature communications, Vol.12 (1), pp. 366-?.  show abstract

Carotenuto, P. Amato, F. Lampis, A. Rae, C. Hedayat, S. Previdi, M.C. Zito, D. Raj, M. Guzzardo, V. Sclafani, F. Lanese, A. Parisi, C. Vicentini, C. Said-Huntingford, I. Hahne, J.C. Hallsworth, A. Kirkin, V. Young, K. Begum, R. Wotherspoon, A. Kouvelakis, K. Azevedo, S.X. Michalarea, V. Upstill-Goddard, R. Rao, S. Watkins, D. Starling, N. Sadanandam, A. Chang, D.K. Biankin, A.V. Jamieson, N.B. Scarpa, A. Cunningham, D. Chau, I. Workman, P. Fassan, M. Valeri, N. Braconi, C. (2021). Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. Nat commun, Vol.12 (1), pp. 6738-?.  show abstract

Rata, M. Khan, K. Collins, D.J. Koh, D.-. Tunariu, N. Bali, M.A. d'Arcy, J. Winfield, J.M. Picchia, S. Valeri, N. Chau, I. Cunningham, D. Fassan, M. Leach, M.O. Orton, M.R. (2021). DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastases. Cancer imaging : the official publication of the international cancer imaging society, Vol.21 (1), pp. 67-?.  show abstract

Georgiou, A. Stewart, A. Vlachogiannis, G. Pickard, L. Valeri, N. Cunningham, D. Whittaker, S.R. Banerji, U. (2021). A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAF(V600) wild-type colorectal cancer. Cellular oncology, , pp. ?-? (10).

Khan, K. Gonzalez-Exposito, R. Cunningham, D. Koh, D.-. Woolston, A. Barber, L. Griffiths, B. Kouvelakis, K. Calamai, V. Bali, M. Khan, N. Bryant, A. Saffery, C. Dearman, C. Begum, R. Rao, S. Starling, N. Watkins, D. Chau, I. Braconi, C. Valeri, N. Gerlinger, M. Fotiadis, N. (2020). Diagnostic Accuracy and Safety of Coaxial System in Oncology Patients Treated in a Specialist Cancer Center With Prospective Validation Within Clinical Trial Data. Frontiers in oncology, Vol.10, pp. 1634-?.  show abstract

Kühnl, A. Peckitt, C. Patel, B. Ardeshna, K.M. Macheta, M.P. Radford, J. Johnson, R. Paneesha, S. Barton, S. Chau, I. Begum, R. Valeri, N. Wotherspoon, A. Du, Y. Zerizer, I. Cunningham, D. (2020). R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial. Annals of hematology, Vol.99 (1), pp. 105-112.

Khakoo, S. Carter, P.D. Brown, G. Valeri, N. Picchia, S. Bali, M.A. Shaikh, R. Jones, T. Begum, R. Rana, I. Wotherspoon, A. Terlizzo, M. von Loga, K. Kalaitzaki, E. Saffery, C. Watkins, D. Tait, D. Chau, I. Starling, N. Hubank, M. Cunningham, D. (2020). MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer. Clinical cancer research, Vol.26 (1), pp. 183-192.  show abstract

Lampis, A. Ghidini, M. Ratti, M. Mirchev, M.B. Okuducu, A.F. Valeri, N. Hahne, J.C. (2020). Circulating Tumour DNAs and Non-Coding RNAs as Liquid Biopsies for the Management of Colorectal Cancer Patients. Gastrointestinal disorders, Vol.2 (3), pp. 212-235 (24).

Fassan, M. Realdon, S. Cascione, L. Hahne, J.C. Munari, G. Guzzardo, V. Arcidiacono, D. Lampis, A. Brignola, S. Dal Santo, L. Agostini, M. Bracon, C. Maddalo, G. Scarpa, M. Farinati, F. Zaninotto, G. Valeri, N. Rugge, M. (2020). Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett’s carcinogenesis. Pathology - research and practice, Vol.216 (5), pp. 152907-152907.

Ratti, M. Lampis, A. Ghidini, M. Salati, M. Mirchev, M.B. Valeri, N. Hahne, J.C. (2020). MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside. Targeted oncology, Vol.15 (3), pp. 261-278.  show abstract

Loupakis, F. Depetris, I. Biason, P. Intini, R. Prete, A.A. Leone, F. Lombardi, P. Filippi, R. Spallanzani, A. Cascinu, S. Bonetti, L.R. Maddalena, G. Valeri, N. Sottoriva, A. Zapata, L. Salmaso, R. Munari, G. Rugge, M. Dei Tos, A.P. Golovato, J. Sanborn, J.Z. Nguyen, A. Schirripa, M. Zagonel, V. Lonardi, S. Fassan, M. (2020). Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes. The oncologist, Vol.25 (6), pp. 481-487.  show abstract

Carotenuto, P. Hedayat, S. Fassan, M. Cardinale, V. Lampis, A. Guzzardo, V. Vicentini, C. Scarpa, A. Cascione, L. Costantini, D. Carpino, G. Alvaro, D. Ghidini, M. Trevisani, F. Te Poele, R. Salati, M. Ventura, S. Vlachogiannis, G. Hahne, J.C. Boulter, L. Forbes, S.J. Guest, R.V. Cillo, U. Said-Huntingford, I. Begum, R. Smyth, E. Michalarea, V. Cunningham, D. Rimassa, L. Santoro, A. Roncalli, M. Kirkin, V. Clarke, P. Workman, P. Valeri, N. Braconi, C. (2020). Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells. Hepatology (baltimore, md.), Vol.72 (3), pp. 982-996.  show abstract

Lampis, A. Hahne, J.C. Hedayat, S. Valeri, N. (2020). MicroRNAs as mediators of drug resistance mechanisms. Current opinion in pharmacology, Vol.54, pp. 44-50.  show abstract

Hahne, J.C. Lampis, A. Valeri, N. (2020). Vault RNAs: hidden gems in RNA and protein regulation. Cellular and molecular life sciences : cmls, .  show abstract

Smyth, E.C. Vlachogiannis, G. Hedayat, S. Harbery, A. Hulkki-Wilson, S. Salati, M. Kouvelakis, K. Fernandez-Mateos, J. Cresswell, G.D. Fontana, E. Seidlitz, T. Peckitt, C. Hahne, J.C. Lampis, A. Begum, R. Watkins, D. Rao, S. Starling, N. Waddell, T. Okines, A. Crosby, T. Mansoor, W. Wadsley, J. Middleton, G. Fassan, M. Wotherspoon, A. Braconi, C. Chau, I. Vivanco, I. Sottoriva, A. Stange, D.E. Cunningham, D. Valeri, N. (2020). EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers. Gut, .  show abstract

Knight, J.R. Alexandrou, C. Skalka, G.L. Vlahov, N. Pennel, K. Officer, L. Teodosio, A. Kanellos, G. Gay, D.M. May-Wilson, S. Smith, E.M. Najumudeen, A.K. Gilroy, K. Ridgway, R.A. Flanagan, D.J. Smith, R.C. McDonald, L. MacKay, C. Cheasty, A. McArthur, K. Stanway, E. Leach, J.D. Jackstadt, R. Waldron, J.A. Campbell, A.D. Vlachogiannis, G. Valeri, N. Haigis, K.M. Sonenberg, N. Proud, C.G. Jones, N.P. Swarbrick, M.E. McKinnon, H.J. Faller, W.J. Le Quesne, J. Edwards, J. Willis, A.E. Bushell, M. Sansom, O.J. (2020). MNK inhibition sensitizes KRAS-mutant colorectal cancer to mTORC1 inhibition by reducing eIF4E phosphorylation and c-MYC expression. Cancer discovery, .  show abstract

Acar, A. Nichol, D. Fernandez-Mateos, J. Cresswell, G.D. Barozzi, I. Hong, S.P. Trahearn, N. Spiteri, I. Stubbs, M. Burke, R. Stewart, A. Caravagna, G. Werner, B. Vlachogiannis, G. Maley, C.C. Magnani, L. Valeri, N. Banerji, U. Sottoriva, A. (2020). Exploiting evolutionary steering to induce collateral drug sensitivity in cancer. Nature communications, Vol.11 (1), pp. 1923-?.  show abstract

Zaniboni, A. Ghidini, M. Grossi, F. Indini, A. Trevisan, F. Iaculli, A. Dottorini, L. Moleri, G. Russo, A. Vavassori, I. Brevi, A. Rausa, E. Boni, L. Dondossola, D. Valeri, N. Ghidini, A. Tomasello, G. Petrelli, F. (2020). A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic. Cancers, Vol.12 (9).  show abstract

Ghidini, M. Lampis, A. Mirchev, M.B. Okuducu, A.F. Ratti, M. Valeri, N. Hahne, J.C. (2020). Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer. Genes, Vol.12 (1).  show abstract

Fassan, M. Cui, R. Gasparini, P. Mescoli, C. Guzzardo, V. Vicentini, C. Munari, G. Loupakis, F. Lonardi, S. Braconi, C. Scarpa, M. D'Angelo, E. Pucciarelli, S. Angriman, I. Agostini, M. D'Incá, R. Farinati, F. Gafà, R. Lanza, G. Frankel, W.L. Croce, C.M. Valeri, N. Rugge, M. (2019). miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis. Translational oncology, Vol.12 (2), pp. 282-291.  show abstract

Wagner, S. Vlachogiannis, G. De Haven Brandon, A. Valenti, M. Box, G. Jenkins, L. Mancusi, C. Self, A. Manodoro, F. Assiotis, I. Robinson, P. Chauhan, R. Rust, A.G. Matthews, N. Eason, K. Khan, K. Starling, N. Cunningham, D. Sadanandam, A. Isacke, C.M. Kirkin, V. Valeri, N. Whittaker, S.R. (2019). Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer. Oncogene, Vol.38 (10), pp. 1717-1733.  show abstract

Khan, K. Rane, J.K. Cunningham, D. Rao, S. Watkins, D. Starling, N. Kalaitzaki, E. Forster, M. Braconi, C. Valeri, N. Gerlinger, M. Chau, I. (2019). Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience. Clinical colorectal cancer, Vol.18 (1), pp. 64-71.e1.  show abstract

Valeri, N. (2019). Streamlining Detection of Fusion Genes in Colorectal Cancer: Having "Faith" in Precision Oncology in the (Tissue) "Agnostic" Era. Cancer research, Vol.79 (6), pp. 1041-1043.  show abstract

Anandappa, G. Lampis, A. Cunningham, D. Khan, K.H. Kouvelakis, K. Vlachogiannis, G. Hedayat, S. Tunariu, N. Rao, S. Watkins, D. Starling, N. Braconi, C. Darvish-Damavandi, M. Lote, H. Thomas, J. Peckitt, C. Kalaitzaki, R. Khan, N. Fotiadis, N. Rugge, M. Begum, R. Rana, I. Bryant, A. Hahne, J.C. Chau, I. Fassan, M. Valeri, N. (2019). miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial. Clinical cancer research : an official journal of the american association for cancer research, Vol.25 (13), pp. 3830-3838.  show abstract

Salati, M. Valeri, N. Spallanzani, A. Braconi, C. Cascinu, S. (2019). Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications. European journal of surgical oncology, Vol.45 (8), pp. 1479-1482.

Visone, R. Bacalini, M.G. Di Franco, S. Ferracin, M. Colorito, M.L. Pagotto, S. Laprovitera, N. Licastro, D. Di Marco, M. Scavo, E. Bassi, C. Saccenti, E. Nicotra, A. Grzes, M. Garagnani, P. De Laurenzi, V. Valeri, N. Mariani-Costantini, R. Negrini, M. Stassi, G. Veronese, A. (2019). DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells. Epigenomics, Vol.11 (6), pp. 587-604.  show abstract

Khan, K. Valeri, N. Dearman, C. Rao, S. Watkins, D. Starling, N. Chau, I. Cunningham, D. (2019). Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution. Critical reviews in oncology/hematology, Vol.143, pp. 153-163.

Schmidt, S. Gay, D. Uthe, F.W. Denk, S. Paauwe, M. Matthes, N. Diefenbacher, M.E. Bryson, S. Warrander, F.C. Erhard, F. Ade, C.P. Baluapuri, A. Walz, S. Jackstadt, R. Ford, C. Vlachogiannis, G. Valeri, N. Otto, C. Schülein-Völk, C. Maurus, K. Schmitz, W. Knight, J.R. Wolf, E. Strathdee, D. Schulze, A. Germer, C.-. Rosenwald, A. Sansom, O.J. Eilers, M. Wiegering, A. (2019). A MYC–GCN2–eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer. Nature cell biology, Vol.21 (11), pp. 1413-1424.

Fanelli, G.N. Loupakis, F. Smyth, E. Scarpa, M. Lonardi, S. Pucciarelli, S. Munari, G. Rugge, M. Valeri, N. Fassan, M. (2019). Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis. International journal of surgical pathology, Vol.27 (8), pp. 816-835.  show abstract

Pietrantonio, F. Miceli, R. Raimondi, A. Kim, Y.W. Kang, W.K. Langley, R.E. Choi, Y.Y. Kim, K.-. Nankivell, M.G. Morano, F. Wotherspoon, A. Valeri, N. Kook, M.-. An, J.Y. Grabsch, H.I. Fucà, G. Noh, S.H. Sohn, T.S. Kim, S. Di Bartolomeo, M. Cunningham, D. Lee, J. Cheong, J.-. Smyth, E.C. (2019). Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. Journal of clinical oncology : official journal of the american society of clinical oncology, Vol.37 (35), pp. 3392-3400.  show abstract

Fontana, E. Valeri, N. (2019). Class(y) Dissection of BRAF Heterogeneity: Beyond Non-V600. Clinical cancer research : an official journal of the american association for cancer research, Vol.25 (23), pp. 6896-6898.  show abstract

Coati, I. Lotz, G. Fanelli, G.N. Brignola, S. Lanza, C. Cappellesso, R. Pellino, A. Pucciarelli, S. Spolverato, G. Guzzardo, V. Munari, G. Zaninotto, G. Scarpa, M. Mastracci, L. Farinati, F. Realdon, S. Pilati, P. Lonardi, S. Valeri, N. Rugge, M. Kiss, A. Loupakis, F. Fassan, M. (2019). Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases. , Vol.121 (3), pp. 257-263.  show abstract

Moorcraft, S.Y. Gonzalez de Castro, D. Cunningham, D. Jones, T. Walker, B.A. Peckitt, C. Yuan, L.C. Frampton, M. Begum, R. Eltahir, Z. Wotherspoon, A. Teixeira Mendes, L.S. Hulkki Wilson, S. Gillbanks, A. Baratelli, C. Fotiadis, N. Patel, A. Braconi, C. Valeri, N. Gerlinger, M. Rao, S. Watkins, D. Chau, I. Starling, N. (2018). Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice. Annals of oncology, Vol.29 (1), pp. 230-236.

Hahne, J.C. Valeri, N. (2018). Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors. Frontiers in oncology, Vol.8, pp. 226-?.  show abstract

Fassan, M. Vianello, L. Sacchi, D. Fanelli, G.N. Munari, G. Scarpa, M. Cappellesso, R. Loupakis, F. Lanza, C. Salmaso, R. Mescoli, C. Valeri, N. Agostini, M. D'Angelo, E. Lonardi, S. Pucciarelli, S. Veronese, N. Luchini, C. Rugge, M. (2018). Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases. Cancer cell international, Vol.18, pp. 131-?.  show abstract

Vlachogiannis, G. Hedayat, S. Vatsiou, A. Jamin, Y. Fernández-Mateos, J. Khan, K. Lampis, A. Eason, K. Huntingford, I. Burke, R. Rata, M. Koh, D.-. Tunariu, N. Collins, D. Hulkki-Wilson, S. Ragulan, C. Spiteri, I. Moorcraft, S.Y. Chau, I. Rao, S. Watkins, D. Fotiadis, N. Bali, M. Darvish-Damavandi, M. Lote, H. Eltahir, Z. Smyth, E.C. Begum, R. Clarke, P.A. Hahne, J.C. Dowsett, M. de Bono, J. Workman, P. Sadanandam, A. Fassan, M. Sansom, O.J. Eccles, S. Starling, N. Braconi, C. Sottoriva, A. Robinson, S.P. Cunningham, D. Valeri, N. (2018). Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science (new york, n.y.), Vol.359 (6378), pp. 920-926.  show abstract

Lampis, A. Carotenuto, P. Vlachogiannis, G. Cascione, L. Hedayat, S. Burke, R. Clarke, P. Bosma, E. Simbolo, M. Scarpa, A. Yu, S. Cole, R. Smyth, E. Mateos, J.F. Begum, R. Hezelova, B. Eltahir, Z. Wotherspoon, A. Fotiadis, N. Bali, M.A. Nepal, C. Khan, K. Stubbs, M. Hahne, J.C. Gasparini, P. Guzzardo, V. Croce, C.M. Eccles, S. Fassan, M. Cunningham, D. Andersen, J.B. Workman, P. Valeri, N. Braconi, C. (2018). MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma. Gastroenterology, Vol.154 (4), pp. 1066-1079.e5.  show abstract

Smyth, E. Khan, K. Valeri, N. (2018). Translational research and application of basic biology to clinical trial development in GI cancers. Annals of translational medicine, Vol.6 (9), pp. 164-164.

Davarzani, N. Hutchins, G.G. West, N.P. Hewitt, L.C. Nankivell, M. Cunningham, D. Allum, W.H. Smyth, E. Valeri, N. Langley, R.E. Grabsch, H.I. (2018). Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial. Histopathology, Vol.72 (7), pp. 1180-1188.  show abstract

Khan, K. Rata, M. Cunningham, D. Koh, D.-. Tunariu, N. Hahne, J.C. Vlachogiannis, G. Hedayat, S. Marchetti, S. Lampis, A. Damavandi, M.D. Lote, H. Rana, I. Williams, A. Eccles, S.A. Fontana, E. Collins, D. Eltahir, Z. Rao, S. Watkins, D. Starling, N. Thomas, J. Kalaitzaki, E. Fotiadis, N. Begum, R. Bali, M. Rugge, M. Temple, E. Fassan, M. Chau, I. Braconi, C. Valeri, N. (2018). Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study. Gut, Vol.67 (8), pp. 1484-1492.  show abstract

Ghidini, M. Hahne, J.C. Frizziero, M. Tomasello, G. Trevisani, F. Lampis, A. Passalacqua, R. Valeri, N. (2018). MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours. Targeted oncology, Vol.13 (4), pp. 423-436.  show abstract

Khan, K.H. Cunningham, D. Werner, B. Vlachogiannis, G. Spiteri, I. Heide, T. Mateos, J.F. Vatsiou, A. Lampis, A. Damavandi, M.D. Lote, H. Huntingford, I.S. Hedayat, S. Chau, I. Tunariu, N. Mentrasti, G. Trevisani, F. Rao, S. Anandappa, G. Watkins, D. Starling, N. Thomas, J. Peckitt, C. Khan, N. Rugge, M. Begum, R. Hezelova, B. Bryant, A. Jones, T. Proszek, P. Fassan, M. Hahne, J.C. Hubank, M. Braconi, C. Sottoriva, A. Valeri, N. (2018). Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial. Cancer discovery, Vol.8 (10), pp. 1270-1285.  show abstract

Ratti, M. Lampis, A. Hahne, J.C. Passalacqua, R. Valeri, N. (2018). Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches. Cellular and molecular life sciences : cmls, Vol.75 (22), pp. 4151-4162.  show abstract

Sundar, R. Miranda, S. Rodrigues, D.N. Chénard-Poirier, M. Dolling, D. Clarke, M. Figueiredo, I. Bertan, C. Yuan, W. Ferreira, A. Chistova, R. Boysen, G. Perez, D.R. Tunariu, N. Mateo, J. Wotherspoon, A. Chau, I. Cunningham, D. Valeri, N. Carreira, S. de Bono, J. (2018). Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer. Clinical colorectal cancer, Vol.17 (4), pp. 280-284.  show abstract

Mensah, A.A. Cascione, L. Gaudio, E. Tarantelli, C. Bomben, R. Bernasconi, E. Zito, D. Lampis, A. Hahne, J.C. Rinaldi, A. Stathis, A. Zucca, E. Kwee, I. Gattei, V. Valeri, N. Riveiro, M.E. Bertoni, F. (2018). Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma. Haematologica, Vol.103 (12), pp. 2049-2058.  show abstract

Smyth, E.C. Nyamundanda, G. Cunningham, D. Fontana, E. Ragulan, C. Tan, I.B. Lin, S.J. Wotherspoon, A. Nankivell, M. Fassan, M. Lampis, A. Hahne, J.C. Davies, A.R. Lagergren, J. Gossage, J.A. Maisey, N. Green, M. Zylstra, J.L. Allum, W.H. Langley, R.E. Tan, P. Valeri, N. Sadanandam, A. (2018). A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial. Annals of oncology : official journal of the european society for medical oncology, Vol.29 (12), pp. 2356-2362.  show abstract

Fanelli, G.N. Gasparini, P. Coati, I. Cui, R. Pakula, H. Chowdhury, B. Valeri, N. Loupakis, F. Kupcinskas, J. Cappellesso, R. Fassan, M. (2018). LONG-NONCODING RNAs in gastroesophageal cancers. Non-coding rna research, Vol.3 (4), pp. 195-212.  show abstract

Davies, A.R. Myoteri, D. Zylstra, J. Baker, C.R. Wulaningsih, W. Van Hemelrijck, M. Maisey, N. Allum, W.H. Smyth, E. Gossage, J.A. Lagergren, J. Cunningham, D. Green, M. Kelly, M. Ngan, S. Qureshi, A. Gaya, A. Griffin, N. Jacques, A. Goh, V. Deere, H. Chang, F. Mahadeva, U. Gill-Barman, B. George, S. Dunn, J. Zeki, S. Meenan, J. Hynes, O. Tham, G. Iezzi, C. Dellaportas, D. Cowie, A. Knight, W. Valeri, N. (2018). Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma. British journal of surgery, Vol.105 (12), pp. 1639-1649.  show abstract

Lote, H. Valeri, N. Chau, I. (2018). HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer. World j gastrointest oncol, Vol.10, pp. 159-171.  show abstract

Sclafani, F. Chau, I. Cunningham, D. Hahne, J.C. Vlachogiannis, G. Eltahir, Z. Lampis, A. Braconi, C. Kalaitzaki, E. De Castro, D.G. Wotherspoon, A. Capdevila, J. Glimelius, B. Tarazona, N. Begum, R. Lote, H. Hulkki Wilson, S. Mentrasti, G. Brown, G. Tait, D. Oates, J. Valeri, N. (2018). KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer. Scientific reports, Vol.8 (1), pp. 1445-?.  show abstract

Smyth, E.C. Wotherspoon, A. Peckitt, C. Gonzalez, D. Hulkki-Wilson, S. Eltahir, Z. Fassan, M. Rugge, M. Valeri, N. Okines, A. Hewish, M. Allum, W. Stenning, S. Nankivell, M. Langley, R. Cunningham, D. (2017). Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial. Jama oncol, Vol.3 (9), pp. 1197-1203.  show abstract

Fassan, M. Saraggi, D. Balsamo, L. Realdon, S. Scarpa, M. Castoro, C. Coati, I. Salmaso, R. Farinati, F. Guzzardo, V. Arcidiacono, D. Munari, G. Gasparini, P. Veronese, N. Luchini, C. Valeri, N. Rugge, M. (2017). Early miR-223 Upregulation in Gastroesophageal Carcinogenesis. Am j clin pathol, Vol.147 (3), pp. 301-308.  show abstract

Sundar, R. Valeri, N. Harrington, K.J. Yap, T.A. (2017). Combining Molecularly Targeted Agents: Is More Always Better?. Clinical cancer research : an official journal of the american association for cancer research, Vol.23 (5), pp. 1123-1125.  show abstract

Tomasello, G. Valeri, N. Ghidini, M. Smyth, E.C. Liguigli, W. Toppo, L. Mattioli, R. Curti, A. Hahne, J.C. Negri, F.M. Panni, S. Ratti, M. Lazzarelli, S. Gerevini, F. Colombi, C. Panni, A. Rovatti, M. Treccani, L. Martinotti, M. Passalacqua, R. (2017). First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study. Oncotarget, Vol.8 (67), pp. 111795-111806.  show abstract

Saraggi, D. Fassan, M. Mescoli, C. Scarpa, M. Valeri, N. Michielan, A. D'Incá, R. Rugge, M. (2017). The molecular landscape of colitis-associated carcinogenesis. Digestive and liver disease : official journal of the italian society of gastroenterology and the italian association for the study of the liver, Vol.49 (4), pp. 326-330.  show abstract

Lote, H. Spiteri, I. Ermini, L. Vatsiou, A. Roy, A. McDonald, A. Maka, N. Balsitis, M. Bose, N. Simbolo, M. Mafficini, A. Lampis, A. Hahne, J.C. Trevisani, F. Eltahir, Z. Mentrasti, G. Findlay, C. Kalkman, E.A. Punta, M. Werner, B. Lise, S. Aktipis, A. Maley, C. Greaves, M. Braconi, C. White, J. Fassan, M. Scarpa, A. Sottoriva, A. Valeri, N. (2017). Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer. Annals of oncology : official journal of the european society for medical oncology, Vol.28 (6), pp. 1243-1249.  show abstract

Carotenuto, P. Fassan, M. Pandolfo, R. Lampis, A. Vicentini, C. Cascione, L. Paulus-Hock, V. Boulter, L. Guest, R. Quagliata, L. Hahne, J.C. Ridgway, R. Jamieson, T. Athineos, D. Veronese, A. Visone, R. Murgia, C. Ferrari, G. Guzzardo, V. Evans, T.R. MacLeod, M. Feng, G.J. Dale, T. Negrini, M. Forbes, S.J. Terracciano, L. Scarpa, A. Patel, T. Valeri, N. Workman, P. Sansom, O. Braconi, C. (2017). Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers. Gut, Vol.66 (7), pp. 1268-1277.  show abstract

Ghidini, M. Cascione, L. Carotenuto, P. Lampis, A. Trevisani, F. Previdi, M.C. Hahne, J.C. Said-Huntingford, I. Raj, M. Zerbi, A. Mescoli, C. Cillo, U. Rugge, M. Roncalli, M. Torzilli, G. Rimassa, L. Santoro, A. Valeri, N. Fassan, M. Braconi, C. (2017). Characterisation of the immune-related transcriptome in resected biliary tract cancers. European journal of cancer (oxford, england : 1990), Vol.86, pp. 158-165.  show abstract

Smyth, E. Zhang, S. Cunningham, D. Wotherspoon, A. Soong, R. Peckitt, C. Valeri, N. Fassan, M. Rugge, M. Okines, A. Allum, W. Stenning, S. Nankivell, M. Langley, R. Tan, P. (2017). Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy. Clinical cancer research : an official journal of the american association for cancer research, Vol.23 (24), pp. 7543-7549.  show abstract

Battersby, N.J. Dattani, M. Rao, S. Cunningham, D. Tait, D. Adams, R. Moran, B.J. Khakoo, S. Tekkis, P. Rasheed, S. Mirnezami, A. Quirke, P. West, N.P. Nagtegaal, I. Chong, I. Sadanandam, A. Valeri, N. Thomas, K. Frost, M. Brown, G. (2017). A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial. Trials, Vol.18 (1), pp. 394-?.  show abstract

Saraggi, D. Fassan, M. Bornschein, J. Farinati, F. Realdon, S. Valeri, N. Rugge, M. (2016). From Barrett metaplasia to esophageal adenocarcinoma: the molecular background. Histology and histopathology, Vol.31 (1), pp. 25-32.

Sclafani, F. Chau, I. Cunningham, D. Lampis, A. Hahne, J.C. Ghidini, M. Lote, H. Zito, D. Tabernero, J. Glimelius, B. Cervantes, A. Begum, R. De Castro, D.G. Wilson, S.H. Peckitt, C. Eltahir, Z. Wotherspoon, A. Tait, D. Brown, G. Oates, J. Braconi, C. Valeri, N. (2016). Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients. Carcinogenesis, Vol.37 (9), pp. 852-857.  show abstract

Smyth, E.C. Fassan, M. Cunningham, D. Allum, W.H. Okines, A.F. Lampis, A. Hahne, J.C. Rugge, M. Peckitt, C. Nankivell, M. Langley, R. Ghidini, M. Braconi, C. Wotherspoon, A. Grabsch, H.I. Valeri, N. (2016). Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. J clin oncol, Vol.34 (23), pp. 2721-2727.  show abstract

Trevisani, F. Ghidini, M. Larcher, A. Lampis, A. Lote, H. Manunta, P. Alibrandi, M.T. Zagato, L. Citterio, L. Dell'Antonio, G. Carenzi, C. Capasso, G. Rugge, M. Rigotti, P. Bertini, R. Cascione, L. Briganti, A. Salonia, A. Benigni, F. Braconi, C. Fassan, M. Hahne, J.C. Montorsi, F. Valeri, N. (2016). MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma. British journal of cancer, Vol.115 (11), pp. 1343-1350.  show abstract

Fassan, M. Saraggi, D. Balsamo, L. Cascione, L. Castoro, C. Coati, I. De Bernard, M. Farinati, F. Guzzardo, V. Valeri, N. Zambon, C.F. Rugge, M. (2016). Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis. Oncotarget, Vol.7 (4), pp. 4915-4924.

Sclafani, F. Chau, I. Cunningham, D. Peckitt, C. Lampis, A. Hahne, J.C. Braconi, C. Tabernero, J. Glimelius, B. Cervantes, A. Begum, R. Gonzalez De Castro, D. Hulkki Wilson, S. Eltahir, Z. Wotherspoon, A. Tait, D. Brown, G. Oates, J. Valeri, N. (2015). Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial. Annals of oncology : official journal of the european society for medical oncology, Vol.26 (9), pp. 1936-1941.  show abstract

Slattery, M.L. Herrick, J.S. Mullany, L.E. Valeri, N. Stevens, J. Caan, B.J. Samowitz, W. Wolff, R.K. (2015). An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int j cancer, Vol.137 (2), pp. 428-438.  show abstract

Cordero, J.B. Ridgway, R.A. Valeri, N. Nixon, C. Frame, M.C. Muller, W.J. Vidal, M. Sansom, O.J. (2014). c-Src drives intestinal regeneration and transformation. Embo j, Vol.33 (13), pp. 1474-1491.  show abstract

Ryan, B.M. Wolff, R.K. Valeri, N. Khan, M. Robinson, D. Paone, A. Bowman, E.D. Lundgreen, A. Caan, B. Potter, J. Brown, D. Croce, C. Slattery, M.L. Harris, C.C. (2014). An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. Cancer epidemiol, Vol.38 (5), pp. 583-590.  show abstract

Valeri, N. Braconi, C. Gasparini, P. Murgia, C. Lampis, A. Paulus-Hock, V. Hart, J.R. Ueno, L. Grivennikov, S.I. Lovat, F. Paone, A. Cascione, L. Sumani, K.M. Veronese, A. Fabbri, M. Carasi, S. Alder, H. Lanza, G. Gafa', R. Moyer, M.P. Ridgway, R.A. Cordero, J. Nuovo, G.J. Frankel, W.L. Rugge, M. Fassan, M. Groden, J. Vogt, P.K. Karin, M. Sansom, O.J. Croce, C.M. (2014). MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer. Cancer cell, Vol.25 (4), pp. 469-483.

Fassan, M. Dall'Olmo, L. Galasso, M. Braconi, C. Pizzi, M. Realdon, S. Volinia, S. Valeri, N. Gasparini, P. Baffa, R. Souza, R.F. Vicentini, C. D'Angelo, E. Bornschein, J. Nuovo, G.J. Zaninotto, G. Croce, C.M. Rugge, M. (2014). Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. Oncotarget, Vol.5 (16), pp. 7162-7171.

Valeri, N. Braconi, C. Gasparini, P. Grivennikow, S. Hart, J.R. Paone, A. Lovat, F. Fabbri, M. Gafa', R. Nuovo, G. Lanza, G. Frankel, W. Vogt, P.K. Groden, J. Karin, M. Croce, C.M. (2012). Anti-miR-135b in colon cancer treatment: Results from a preclinical study. Journal of clinical oncology, Vol.30 (4_suppl), pp. 457-457.  show abstract

Valeri, N. Braconi, C. Gasparini, P. Grivennikow, S. Hart, J.R. Paone, A. Lovat, F. Fabbri, M. Gafa', R. Nuovo, G. Lanza, G. Frankel, W. Vogt, P.K. Groden, J. Karin, M. Croce, C.M. (2012). Anti-miR-135b in colon cancer treatment: Results from a preclinical study. J clin oncol, Vol.30 (4_suppl), p. 457.  show abstract

Nuovo, G.J. Garofalo, M. Valeri, N. Roulstone, V. Volinia, S. Cohn, D.E. Phelps, M. Harrington, K.J. Vile, R. Melcher, A. Galanis, E. Sehl, S. Adair, R. Scott, K. Rose, A. Toogood, G. Coffey, M.C. (2012). Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples. Mod pathol, Vol.25 (10), pp. 1333-1344.  show abstract

Ryan, B.M. McClary, A.C. Valeri, N. Robinson, D. Paone, A. Bowman, E.D. Robles, A.I. Croce, C. Harris, C.C. (2012). rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. Plos one, Vol.7 (5), p. e36306.  show abstract

Valeri, N. Gasparini, P. Braconi, C. Lovat, F. Paone, A. Fabbri, M. Nuovo, G. Fishel, R. Croce, C.M. (2011). Effect of miR-21 on resistance to 5-fluorouracil and regulation of MSH2. Journal of clinical oncology, Vol.29 (4_suppl), pp. 431-431.  show abstract

Braconi, C. Kogure, T. Valeri, N. Gasparini, P. Huang, N. Nuovo, G. Terracciano, L. Croce, C.M. Patel, T. (2011). Effect of the ultraconserved noncoding RNA uc 338 on cellular growth of hepatocarcinoma. Journal of clinical oncology, Vol.29 (4_suppl), pp. 202-202.  show abstract

Voltan, R. di Iasio, M.G. Bosco, R. Valeri, N. Pekarski, Y. Tiribelli, M. Secchiero, P. Zauli, G. (2011). Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells. Clin cancer res, Vol.17 (17), pp. 5649-5655.  show abstract

Valeri, N. Gasparini, P. Braconi, C. Lovat, F. Paone, A. Fabbri, M. Nuovo, G. Fishel, R. Croce, C.M. (2011). Effect of miR-21 on resistance to 5-fluorouracil and regulation of MSH2. J clin oncol, Vol.29 (4_suppl), p. 431.  show abstract

Braconi, C. Kogure, T. Valeri, N. Gasparini, P. Huang, N. Nuovo, G. Terracciano, L. Croce, C.M. Patel, T. (2011). Effect of the ultraconserved noncoding RNA uc 338 on cellular growth of hepatocarcinoma. J clin oncol, Vol.29 (4_suppl), p. 202.  show abstract

Fabbri, M. Bottoni, A. Shimizu, M. Spizzo, R. Nicoloso, M.S. Rossi, S. Barbarotto, E. Cimmino, A. Adair, B. Wojcik, S.E. Valeri, N. Calore, F. Sampath, D. Fanini, F. Vannini, I. Musuraca, G. Dell'Aquila, M. Alder, H. Davuluri, R.V. Rassenti, L.Z. Negrini, M. Nakamura, T. Amadori, D. Kay, N.E. Rai, K.R. Keating, M.J. Kipps, T.J. Calin, G.A. Croce, C.M. (2011). Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. Jama, Vol.305 (1), pp. 59-67.  show abstract

Braconi, C. Valeri, N. Kogure, T. Gasparini, P. Huang, N. Nuovo, G.J. Terracciano, L. Croce, C.M. Patel, T. (2011). Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc natl acad sci u s a, Vol.108 (2), pp. 786-791.  show abstract

Lovat, F. Valeri, N. Croce, C.M. (2011). MicroRNAs in the pathogenesis of cancer. Semin oncol, Vol.38 (6), pp. 724-733.  show abstract

Braconi, C. Kogure, T. Valeri, N. Nuovo, G. Costinean, S. Croce, C.M. Patel, T. (2011). Abstract 1178: Involvement of MEG3, a long non-coding RNA, in hepatocellular cancer (HCC). Cancer research, Vol.71 (8_Supplement), pp. 1178-1178.  show abstract

Braconi, C. Kogure, T. Valeri, N. Huang, N. Nuovo, G. Costinean, S. Negrini, M. Miotto, E. Croce, C.M. Patel, T. (2011). microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene, Vol.30 (47), pp. 4750-4756.  show abstract

Braconi, C. Valeri, N. Gasparini, P. Huang, N. Taccioli, C. Nuovo, G. Suzuki, T. Croce, C.M. Patel, T. (2010). Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. Clin cancer res, Vol.16 (3), pp. 957-966.  show abstract

Braconi, C. Kogure, T. Valeri, N. Huang, N. Gasparini, P. Nuovo, G. Terracciano, L. Croce, C.M. Patel, T. (2010). Ultraconserved non-coding RNAs are involved in human hepatocellular cancer growth. Cancer research, Vol.70.

Cohn, D.E. Fabbri, M. Valeri, N. Alder, H. Ivanov, I. Liu, C.-. Croce, C.M. Resnick, K.E. (2010). Comprehensive miRNA profiling of surgically staged endometrial cancer. Am j obstet gynecol, Vol.202 (6), pp. 656.e1-656.e8.  show abstract

Valeri, N. Gasparini, P. Braconi, C. Paone, A. Lovat, F. Fabbri, M. Sumani, K.M. Alder, H. Amadori, D. Patel, T. Nuovo, G.J. Fishel, R. Croce, C.M. (2010). MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc natl acad sci u s a, Vol.107 (49), pp. 21098-21103.  show abstract

Valeri, N. Gasparini, P. Fabbri, M. Braconi, C. Veronese, A. Lovat, F. Adair, B. Vannini, I. Fanini, F. Bottoni, A. Costinean, S. Sandhu, S.K. Nuovo, G.J. Alder, H. Gafa, R. Calore, F. Ferracin, M. Lanza, G. Volinia, S. Negrini, M. McIlhatton, M.A. Amadori, D. Fishel, R. Croce, C.M. (2010). Modulation of mismatch repair and genomic stability by miR-155. Proc natl acad sci u s a, Vol.107 (15), pp. 6982-6987.  show abstract

Braconi, C. Kogure, T. Valeri, N. Huang, N. Gasparini, P. Nuovo, G. Terracciano, L. Croce, C.M. Patel, T. (2010). Abstract 4086: Ultraconserved non-coding RNAs are involved in human hepatocellular cancer growth. Cancer research, Vol.70 (8_Supplement), pp. 4086-4086.  show abstract

Fabbri, M. Adair, B. Wernicke, D. Garzon, R. Valeri, N. Cimmino, A. Zanesi, N. Croce, C. (2009). MicroRNA 29 family restores estrogen receptor and selective estrogen receptors regulators (SERMs) sensitivity in breast cancer. Cancer research, Vol.69.

Fabbri, M. Valeri, N. Calin, G.A. (2009). MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift. Carcinogenesis, Vol.30 (6), pp. 912-917.  show abstract

Valeri, N. Croce, C.M. Fabbri, M. (2009). Pathogenetic and clinical relevance of microRNAs in colorectal cancer. Cancer genomics proteomics, Vol.6 (4), pp. 195-204.  show abstract

Valeri, N. Vannini, I. Fanini, F. Calore, F. Adair, B. Fabbri, M. (2009). Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation. Mamm genome, Vol.20 (9-10), pp. 573-580.  show abstract

Resnick, K.E. Fabbri, M. Valeri, N. Alder, H. Taccioli, C. Liu, C.-. Cohn, D.E. Croce, C.M. (2008). MiRNA profile in stage 1, surgically staged endometrial cancer and predicted downstream targets. Gynecologic oncology, Vol.108 (3), pp. S11-S11.

Braconi, C. Bracci, R. Bearzi, I. Bianchi, F. Costagliola, A. Catalani, R. Mandolesi, A. Ranaldi, R. Galizia, E. Cascinu, S. Rossi, G. Giustini, L. Latini, L. Valeri, N. Cellerino, R. (2008). KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study. Ann oncol, Vol.19 (4), pp. 706-710.  show abstract

Braconi, C. Bracci, R. Bearzi, I. Bianchi, F. Sabato, S. Mandolesi, A. Belvederesi, L. Cascinu, S. Valeri, N. Cellerino, R. (2008). Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients. Ann oncol, Vol.19 (7), pp. 1293-1298.  show abstract

Cascinu, S. Verdecchia, L. Valeri, N. Berardi, R. Scartozzi, M. (2006). New target therapies in advanced pancreatic cancer. Ann oncol, Vol.17 Suppl 5, pp. v148-v152.  show abstract

Valeri, N. Battelli, N. Mariotti, C. Santinelli, A. Siquini, W. Gusella, P. Braconi, C. Lippe, P. Cascinu Prof, S. (2006). CEA as a prognostic factor in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy. J clin oncol, Vol.24 (18_suppl), p. 10705.  show abstract

Amodio, V. Yaeger, R. Arcella, P. Cancelliere, C. Lamba, S. Lorenzato, A. Arena, S. Montone, M. Mussolin, B. Bian, Y. Whaley, A. Pinnelli, M. Murciano-Goroff, Y.R. Vakiani, E. Valeri, N. Liao, W.-. Bhalkikar, A. Thyparambil, S. Zhao, H.-. de Stanchina, E. Marsoni, S. Siena, S. Bertotti, A. Trusolino, L. Li, B.T. Rosen, N. Di Nicolantonio, F. Bardelli, A. Misale, S. EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer. Cancer discovery, Vol.10 (8), pp. 1129-1139.  show abstract

Lampis, A. Ratti, M. Ghidini, M. Mirchev, M.B. Okuducu, A.F. Valeri, N. Hahne, J.C. Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review). International journal of molecular medicine, Vol.47 (6).  show abstract

Angerilli, V. Fontana, E. Lonardi, S. Sbaraglia, M. Borelli, B. Munari, G. Salmaso, R. Guzzardo, V. Spolverato, G. Pucciarelli, S. Pilati, P. Hahne, J.C. Bergamo, F. Zagonel, V. Dei Tos, A.P. Sadanandam, A. Loupakis, F. Valeri, N. Fassan, M. Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas. Esmo open, Vol.6 (4), pp. 100211-?.  show abstract

Book Chapters

Hahne, J. Honig, A. Engel, J.B. Lampis, A. Valeri, N. Analysing Molecular Mechanism Related to Therapy-Resistance in In-vitro Models of Ovarian Cancer. .

Patents and patent applications

Ghidini, M.Hahne, J.C.Senti, C.Lampis, A.Ratti, M.Pizzo, C.Tomasello, G.Passalacqua, R.Valeri, N. (2019). Circulating-free DNA analysis from long-term surviving metastatic colorectal cancer patients undergoing surgery for resectable disease.

Hutchins, G.G.Davarzani, N.West, N.P.Hewitt, L.Nankivell, M.Cunningham, D.Allum, W.H.Smyth, E.Valeri, N.Langley, R.E.Grabsch, H.I. (2018). Defining the Clinical Value of Pathological Lymph Node Status and Primary Tumour Regression Grading Following Neoadjuvant Therapy in Oesophageal Cancer: Results from the MRC OE02 Trial.

Valeri, N.Croce, C.M. Materials and Methods Related to Modulation of Mismatch Repair and Genomic Stability by miR-155.